This page was reviewed under our medical and editorial policy by
Maurie Markman, MD, President, Medicine & Science.
This page was updated on May 10, 2022.
In many cases, prostate cancer cells are less aggressive and grow more slowly than cells found in other cancers. As a result, prostate cancer is often diagnosed before it has had a chance to spread, or metastasize, to other parts of the body. In 90 percent of cases, the disease is diagnosed while the cancer is confined to the prostate.
When diagnosed in early stages, prostate cancer is highly treatable. In metastatic or stage 4 prostate cancer, cancer cells break away from the tumor in the prostate and establish new tumors in other parts of the body. An initial diagnosis of metastatic prostate cancer is very rare.
Prostate cancer cells may travel through the lymphatic system or the bloodstream to other areas of the body. Common prostate cancer metastasis sites include:
This article will cover:
Stage 4 prostate cancer is classified into substages, and the subcategory the oncologist assigns helps guide the treatment options:
With metastatic prostate cancer, the patient may notice different symptoms than those generally associated with other stages of the disease. Some of the most frequently occurring stage 4 prostate cancer symptoms include:
Not everyone with metastatic prostate cancer will experience each of these symptoms, but patients should speak with their care teams if they notice any such changes.
As part of patients' ongoing treatment, the care team will regularly test PSA levels. PSA stands for prostate-specific antigen, which can be high in men who have prostate cancer. PSA tests are used not only for the initial cancer diagnosis but also to observe the advancement of the disease over time.
Generally, PSA levels are higher in men with metastatic prostate cancer. However, in rare cases, it’s possible to have a low PSA even if a patient has metastatic disease. For these patients, disease progression is better measured in other ways, such as through imaging tests and biomarker tools.
If a patient has been diagnosed with prostate cancer and he or she is concerned about prostate cancer metastasis, they should talk with a doctor about the risk of prostate cancer metastasis and corresponding treatment options.
Treatments for stage 4 prostate cancer may depend on where in the body the disease has spread. Options include:
Unlike with localized prostate cancer, surgery isn’t usually used to treat metastatic cancer. However, it may be used in some cases if it can help improve a patient’s quality of life, often to resolve urinary problems or stop bleeding.
If prostate cancer is locally advanced and hasn’t spread far, a radical prostatectomy may still be an option. A radical prostatectomy is a surgical procedure in which the prostate is removed, along with any nearby tissue that contains prostate cancer cells.
Radiation therapy may be used to treat men with high-risk prostate cancer or stage 4A cancer (in which the cancer has spread to lymph nodes near the prostate but not to other parts of the body).
In these instances, external beam radiation therapy is commonly used, also known as EBRT. Using an external machine, a doctor sends targeted beams of radiation to the cancer site. It’s administered five days a week in an outpatient facility throughout several weeks.
Radiation may be targeted to prostate cancer that has spread to the bones as well, helping reduce pain.
Metastatic prostate cancer patients may benefit from hormone therapy. Androgen suppression therapy, also known as androgen deprivation therapy (ADT), uses medication to lower androgens (male hormones such as testosterone) created in the testicles, which can fuel cancer growth. Radiation therapy and hormone therapy may be given together.
Chemotherapy may be used for patients with metastatic prostate cancer, with the aim of slowing any further spread of cancer and improving quality of life.
The most commonly used chemotherapy medications, typically given via an intravenous (IV) line, are docetaxel combined with prednisone. However, there are several chemotherapy drugs available, so ask a doctor which types may be most appropriate as an effective prostate cancer treatment.
In some cases, these treatments are considered palliative, intended to relieve difficult symptoms and improve quality of life.
The metastatic prostate cancer prognosis varies from person to person, as every situation is different.
According to the American Cancer Society, regional cancer (which has spread into nearby parts of the body, such as the lymph nodes), has a five-year relative survival rate of more than 99 percent.
For distant cancer (when prostate cancer metastasizes into distant parts of the body), the five-year relative survival rate drops to 31 percent.
Treatments for metastatic prostate cancer often cause side effects that may impact quality of life. Side effects may include:
At City of Hope, our prostate cancer experts work closely with our integrative care team to anticipate potential side effects and work proactively to address issues so patients can better tolerate treatments. Supportive care services designed to help manage side effects include:
Learn more about integrative care
Next topic: What are the stages of prostate cancer?